Literature DB >> 7581424

A two-step iterative algorithm for estimation in nonlinear mixed-effect models with an evaluation in population pharmacokinetics.

F Mentré1, R Gomeni.   

Abstract

This article proposes an EM-like algorithm for estimating, by maximum likelihood, the population parameters of a nonlinear mixed-effect model given sparse individual data. The first step involves Bayesian estimation of the individual parameters. During the second step, population parameters are estimated using a linearization about those Bayesian estimates. This algorithm (implemented in P-PHARM) is evaluated on simulated data, mimicking pharmacokinetic analyses and compared to the First-Order method and the First-Order Conditional Estimates method (both implemented in NONMEM). The accuracy of the results, within few iterations, shows the estimation capabilities of the proposed approach.

Mesh:

Substances:

Year:  1995        PMID: 7581424     DOI: 10.1080/10543409508835104

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  28 in total

1.  Population pharmacokinetics of methadone in opiate users: characterization of time-dependent changes.

Authors:  A Rostami-Hodjegan; K Wolff; A W Hay; D Raistrick; R Calvert; G T Tucker
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

2.  Pharmacokinetics of isepamicin during continuous venovenous hemodiafiltration.

Authors:  D Breilh; B Allaouchiche; H Jaumain; P Boulétreau; D Chassard; I Malbec; D Ducint; M C Saux
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

3.  Software for population pharmacokinetics and pharmacodynamics.

Authors:  L Aarons
Journal:  Clin Pharmacokinet       Date:  1999-04       Impact factor: 6.447

4.  Prediction discrepancies for the evaluation of nonlinear mixed-effects models.

Authors:  France Mentré; Sylvie Escolano
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-11-13       Impact factor: 2.745

Review 5.  Non-linear mixed effects modeling - from methodology and software development to driving implementation in drug development science.

Authors:  Goonaseelan Colin Pillai; France Mentré; Jean-Louis Steimer
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-11-07       Impact factor: 2.745

6.  Improving pharmacokinetic-pharmacodynamic models of muscle relaxants using potentiation modelling.

Authors:  Douglas J Eleveld; Johannes H Proost; Ann De Haes; J Mark K H Wierda
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-02       Impact factor: 2.745

7.  Parametric and nonparametric population methods.

Authors:  Johannes H Proost; Douglas J Eleveld
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

8.  Performance of an iterative two-stage bayesian technique for population pharmacokinetic analysis of rich data sets.

Authors:  Johannes H Proost; Douglas J Eleveld
Journal:  Pharm Res       Date:  2006-11-07       Impact factor: 4.200

9.  Twitch potentiation influences the time course of twitch depression in muscle relaxant studies: a pharmacokinetic-pharmacodynamic explanation.

Authors:  Douglas J Eleveld; Johannes H Proost; J Mark K H Wierda
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-10-12       Impact factor: 2.745

10.  An analysis of whole body tracer kinetics in dynamic PET studies with application to image-based blood input function extraction.

Authors:  Jian Huang; Finbarr O'Sullivan
Journal:  IEEE Trans Med Imaging       Date:  2014-05       Impact factor: 10.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.